Farxiga, also known as dapagliflozin, is a medication commonly prescribed to manage type 2 diabetes by improving blood sugar control. This sodium-glucose cotransporter 2 (SGLT2) inhibitor works by promoting the elimination of excess glucose through urine. The USFDA recently expanded the use of Farxiga for the treatment of heart failure (HF) across the entire range of left-ventricular […]